GuidelinesPrimary Care STG
TB Control Programme: Medicine Regimens in Adults
Pulmonary Tuberculosis
A15.0-3/A15.7-8/A16.0-2/ A16.4/A16.7-8 + (B20.0)
Treatment should be given once daily, seven days per week, in both the intensive and continuation phases.
- R – Rifampicin
- H – Isoniazid
- Z or PZA– Pyrazinamide
- E or EMB – Ethambutol
|
Pre-treatment body weight kg |
Two months initial phase
|
Four months continuation phase
|
|
|
RHZE (150/75/400/275) |
RH |
RH |
|
|
30–37 kg |
2 tablets |
2 tablets |
-
|
|
38–54 kg |
3 tablets |
3 tablets |
|
|
55–70 kg |
4 tablets |
-
|
2 tablets |
|
≥71 kg |
5 tablets |
2 tablets |
|
- Adhere to the correct dose and the duration of treatment
- Weigh patient frequently and adjust the dose according to current weight
Standard Treatment Guidelines and Essential Medicines List for South Africa, Primary Healthcare, 2020-4-Version 1.0_16 September 2024
Chapter 17: Respiratory Conditions_17.4 Pulmonary Tuberculosis (TB)_17.4.1 Pulmonary Tuberculosis (TB) in Adults_17.4.1.2 TB control programme: medicine regimens in adults
Drugs mentioned
ICD-10 codes
- A15.0Tuberculosis of lung, confirmed by sputum microscopy with or without culture
- A15.1Tuberculosis of lung, confirmed by culture only
- A15.2Tuberculosis of lung, confirmed histologically
- A15.3Tuberculosis of lung, confirmed by unspecified means
- A15.7Primary respiratory tuberculosis, confirmed bacteriologically and histologically
- A15.8Other respiratory tuberculosis, confirmed bacteriologically and histologically
- A16.0Tuberculosis of lung, bacteriologically and histologically negative
- A16.1Tuberculosis of lung, bacteriological and histological examination not done
- A16.2Tuberculosis of lung, without mention of bacteriological or histological confirmation
- A16.4Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation
- A16.7Primary respiratory tuberculosis without mention of bacteriological or histological confirmation
- A16.8Other respiratory tuberculosis, without mention of bacteriological or histological confirmation
- B20.0HIV disease resulting in mycobacterial infection